Collaborations have become a critical aspect of the search for new treatments for rare diseases as drug companies, universities, research institutes, and patient groups are forging alliances to leverage their strengths. Outside this year’s J.P. Morgan Healthcare Conference, Global Genes will convene for “Rare in the Square” in San Francisco’s Union Square to provide rare-disease focused companies and organizations a place to network at the heart of the week’s activities. We spoke to Michael Pistone, Director of Marketing, Innovations & Commercialization, at Cincinnati Children’s Hospital Medical Center, about his hospital’s rare disease partnerships with drug companies, how the face of partnering in the rare disease space is evolving, and what he’s hoping for at this year’s “Rare in the Square” event.
 
RARECast is a weekly series by Daniel S. Levine. Levine is an award-winning business journalist who has reported on the life sciences, economic development, and business policy issues throughout his 25-year career. He founded Levine Media Group in 2013, which produces The Bio Report and RARECast podcasts. Read his full bio here. 

X